Identification of Mutations that Encode Drug Resistance in the Polymerase Gene of the Human Immunodeficiency Virus

In vitro selection in MT-4 cells was used to generate human immunodeficiency virus-type 1 (HIV 1) variants that are resistant to 2',3'-dideoxycytidine (ddC), 2',3'-didcoxyinosine (ddI) and the (-) enantiomer of 2' ,3'-dideoxy-3'-thiacytidine (3TC). The complete rev...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhengxian Gu, Hengsheng Fang, Horacio Salomon, Qing Gao, Mark A Wainberg
Format: Article
Language:English
Published: Wiley 1994-01-01
Series:Canadian Journal of Infectious Diseases
Online Access:http://dx.doi.org/10.1155/1994/826340
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564237652721664
author Zhengxian Gu
Hengsheng Fang
Horacio Salomon
Qing Gao
Mark A Wainberg
author_facet Zhengxian Gu
Hengsheng Fang
Horacio Salomon
Qing Gao
Mark A Wainberg
author_sort Zhengxian Gu
collection DOAJ
description In vitro selection in MT-4 cells was used to generate human immunodeficiency virus-type 1 (HIV 1) variants that are resistant to 2',3'-dideoxycytidine (ddC), 2',3'-didcoxyinosine (ddI) and the (-) enantiomer of 2' ,3'-dideoxy-3'-thiacytidine (3TC). The complete reverse transcriptase open reading frames of these viruses, and portions of flanking protease and integrase within the pol gene, were cloned and sequenced by polymerase chain reaction (PCR) techniques. Mulalions were observed at each of amino acid sites 65 (Lys → Arg: AAA → AGA) and 184 (Met → Val: ATG → GTG) when ddC was used in this protocol, and at site 184 only when either 3TC or ddl was employed. These mutations were introduced into the pol gene of infectious recombinant HXB2-D DNA by site-directed mutagenesis to confirm, by viral replication assay, their importance in conferring resistance against these drugs. A recombinant virus containing the site 65 mutation only possessed greater than 10-fold resistance against ddC compared with parental HXB2-D. Moreover, cross-resistance of about 20-fold and threefold, respectively, was delectable against 3TC and dell but not against 3'-azido-3'-deoxthymidine (AZT). When the 65 and 184 mutations were combined into HXB2-D, the resultant construct did not possess higher levels of resistance lo any of these drugs than observed with the site 65 or 184 mutation alone. These mutations were further demonstrated by PCH analysis of peripheral blood mononuclear cells from 10 patients on long term ddC therapy, although variable patterns were observed in terms of which of the two mutations or both were present. Sometimes, the wild-type site 65 codon was also detected, indicating the presence of mixtures of viral quasi-species. Direct cloning and sequencing revealed the site 65 mutation in viruses isolated from patients on prolonged ddC therapy.
format Article
id doaj-art-04acaa5b28314266b4eeaabb0ae864f1
institution Kabale University
issn 1180-2332
language English
publishDate 1994-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases
spelling doaj-art-04acaa5b28314266b4eeaabb0ae864f12025-02-03T01:11:29ZengWileyCanadian Journal of Infectious Diseases1180-23321994-01-015Suppl E29E33E10.1155/1994/826340Identification of Mutations that Encode Drug Resistance in the Polymerase Gene of the Human Immunodeficiency VirusZhengxian GuHengsheng FangHoracio SalomonQing GaoMark A WainbergIn vitro selection in MT-4 cells was used to generate human immunodeficiency virus-type 1 (HIV 1) variants that are resistant to 2',3'-dideoxycytidine (ddC), 2',3'-didcoxyinosine (ddI) and the (-) enantiomer of 2' ,3'-dideoxy-3'-thiacytidine (3TC). The complete reverse transcriptase open reading frames of these viruses, and portions of flanking protease and integrase within the pol gene, were cloned and sequenced by polymerase chain reaction (PCR) techniques. Mulalions were observed at each of amino acid sites 65 (Lys → Arg: AAA → AGA) and 184 (Met → Val: ATG → GTG) when ddC was used in this protocol, and at site 184 only when either 3TC or ddl was employed. These mutations were introduced into the pol gene of infectious recombinant HXB2-D DNA by site-directed mutagenesis to confirm, by viral replication assay, their importance in conferring resistance against these drugs. A recombinant virus containing the site 65 mutation only possessed greater than 10-fold resistance against ddC compared with parental HXB2-D. Moreover, cross-resistance of about 20-fold and threefold, respectively, was delectable against 3TC and dell but not against 3'-azido-3'-deoxthymidine (AZT). When the 65 and 184 mutations were combined into HXB2-D, the resultant construct did not possess higher levels of resistance lo any of these drugs than observed with the site 65 or 184 mutation alone. These mutations were further demonstrated by PCH analysis of peripheral blood mononuclear cells from 10 patients on long term ddC therapy, although variable patterns were observed in terms of which of the two mutations or both were present. Sometimes, the wild-type site 65 codon was also detected, indicating the presence of mixtures of viral quasi-species. Direct cloning and sequencing revealed the site 65 mutation in viruses isolated from patients on prolonged ddC therapy.http://dx.doi.org/10.1155/1994/826340
spellingShingle Zhengxian Gu
Hengsheng Fang
Horacio Salomon
Qing Gao
Mark A Wainberg
Identification of Mutations that Encode Drug Resistance in the Polymerase Gene of the Human Immunodeficiency Virus
Canadian Journal of Infectious Diseases
title Identification of Mutations that Encode Drug Resistance in the Polymerase Gene of the Human Immunodeficiency Virus
title_full Identification of Mutations that Encode Drug Resistance in the Polymerase Gene of the Human Immunodeficiency Virus
title_fullStr Identification of Mutations that Encode Drug Resistance in the Polymerase Gene of the Human Immunodeficiency Virus
title_full_unstemmed Identification of Mutations that Encode Drug Resistance in the Polymerase Gene of the Human Immunodeficiency Virus
title_short Identification of Mutations that Encode Drug Resistance in the Polymerase Gene of the Human Immunodeficiency Virus
title_sort identification of mutations that encode drug resistance in the polymerase gene of the human immunodeficiency virus
url http://dx.doi.org/10.1155/1994/826340
work_keys_str_mv AT zhengxiangu identificationofmutationsthatencodedrugresistanceinthepolymerasegeneofthehumanimmunodeficiencyvirus
AT hengshengfang identificationofmutationsthatencodedrugresistanceinthepolymerasegeneofthehumanimmunodeficiencyvirus
AT horaciosalomon identificationofmutationsthatencodedrugresistanceinthepolymerasegeneofthehumanimmunodeficiencyvirus
AT qinggao identificationofmutationsthatencodedrugresistanceinthepolymerasegeneofthehumanimmunodeficiencyvirus
AT markawainberg identificationofmutationsthatencodedrugresistanceinthepolymerasegeneofthehumanimmunodeficiencyvirus